Trials / Sponsors / Riboscience, LLC.
Riboscience, LLC.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresecta Advanced Unresectable Hepatocellular Carcinoma | Phase 2 | 2026-04-01 |
| Recruiting | Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer Metastatic Colorectal Cancer, Advanced Colorectal Cancer | Phase 2 | 2025-01-17 |
| Recruiting | Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors Advanced Cancer | Phase 1 | 2022-07-11 |
| No Longer Available | Expanded Access RBS2418 Treatment Expanded Access in Pancreatic Cancer | — | — |